Company Filing History:
5 out of 300 
2 out of 26 Years Active: 2021-2025
Title: Jochen Scholz: Innovator in Biopharmaceutical Processes
Introduction
Jochen Scholz is a prominent inventor based in Göttingen, Germany. He has made significant contributions to the field of biopharmaceutical processes, holding a total of seven patents. His innovative work focuses on improving the efficiency and effectiveness of bioreactor plants.
Latest Patents
One of Scholz's latest patents is a system for detecting foam in a bioreactor plant. This system includes a bioreactor plant with at least one disposable container for receiving a medium that may contain foam. It features at least two capacitive sensor units positioned at different locations within the bioreactor plant. These sensor units utilize capacitive measurement to detect foam presence and transmit data to a monitoring unit for controlling foam formation.
Another notable patent is a device and method for compensating short-term pressure or volume fluctuations in a continuous biopharmaceutical process. This device includes a receiving space in fluid communication with a process line, an equalizing space separated by a deflectable element, and a counter-pressure mechanism. The method involves managing excess medium flow and maintaining consistent pressure or flow rates.
Career Highlights
Jochen Scholz has worked with several reputable companies in the biopharmaceutical sector. Notably, he has been associated with Sartorius Stedim Biotech GmbH and The Automation Partnership (Cambridge) Limited. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.
Collaborations
Throughout his career, Scholz has collaborated with notable professionals in the field, including Andreas Prediger and Christian Grimm. These collaborations have further enhanced his contributions to biopharmaceutical technology.
Conclusion
Jochen Scholz is a distinguished inventor whose work in biopharmaceutical processes has led to significant advancements in the industry. His patents reflect a commitment to innovation and efficiency in bioreactor technology.